This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database.
CADTH. Neurofeedback and biofeedback for mood and anxiety disorders: a review of the clinical evidence and guidelines. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). Rapid Response. 2014
Limited evidence since the publication of a previous report suggested that biofeedback (such as heart rate variability biofeedback) may decrease the symptoms of post-traumatic stress disorder or depression. No studies were identified on neurofeedback therapy in the target population. No studies were found on generalized anxiety disorder. No relevant evidence-based guidelines were identified.
Subject indexing assigned by CRD
Anxiety Disorders; Biofeedback, Psychologys; Guidelines as Topic; Mental Health; Mood Disorders; Neurofeedback; Treatment Outcome
Country of organisation
An English language summary is available.
Address for correspondence
Canadian Agency for Drugs and Technologies in Health (CADTH), 865 Carling Avenue, Suite 600, Ottawa, Ontario Canada, K1S 5S8 Email: email@example.com
Date abstract record published